DBVT — DBV Technologies S.A. catalysts
Next verified catalyst
2026-11-01 — Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11 (month) in 4mo
ESTIMATED |
READOUT
Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Ye
Phase 3 · Allergy, Peanut Allergy |
DBVT DBV Technologies S.A. | DBV712 250 mcg |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|